Sickle Cell Disease: A Retrospective Chart Review

Completed

Conditions studied: Sickle Cell Anemia

In brief

This study is a retrospective chart review of sickle cell patients and will include patients whom have received blood transfusions and those whom have not. Of the transfused patients, it will also include those whom have received chelation therapy and those whom have not.

Key facts

Study ID

NCT01441375

Run by

Novartis Pharmaceuticals

People needed

261

Starts

2011-07-01

Expected to finish

2012-07-01

Last updated by the study team

2012-10-18

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a diagnosis of Sickle Cell Disease (SCD) and a confirmed genotype
• Patients ≥ 16 years of age
• Patients with ≥ 6 months of follow-up data available from first SCD treatment at the center after they reach 16 years old
• At least one SF reading during a non-acute phase on or after the first SCD treatment at the center after they reach 16 years old

You may not qualify if…

• Patients who participated in a clinical trial for an iron chelating medication or in a clinical trial for transfusions for SCD (1) within the six months before the index date or (2) during the patient observation period
• Patients with sickle cell trait
• Other protocol-defined inclusion/exclusion criteria may apply

Where it is running

• Tulane University — New Orleans, Louisiana, United States
• Universit of Tennessee — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.